Cargando…

Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin

The Papain-like protease (PLpro) is a domain of a multi-functional, non-structural protein 3 of coronaviruses. PLpro cleaves viral polyproteins and posttranslational conjugates with polyubiquitin and protective ISG15, composed of two ubiquitin-like (UBL) domains. Across coronaviruses, PLpro showed d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wydorski, Pawel M., Osipiuk, Jerzy, Lanham, Benjamin T., Tesar, Christine, Endres, Michael, Engle, Elizabeth, Jedrzejczak, Robert, Mullapudi, Vishruth, Michalska, Karolina, Fidelis, Krzysztof, Fushman, David, Joachimiak, Andrzej, Joachimiak, Lukasz A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094096/
https://www.ncbi.nlm.nih.gov/pubmed/35547846
http://dx.doi.org/10.1101/2021.09.15.460543
Descripción
Sumario:The Papain-like protease (PLpro) is a domain of a multi-functional, non-structural protein 3 of coronaviruses. PLpro cleaves viral polyproteins and posttranslational conjugates with polyubiquitin and protective ISG15, composed of two ubiquitin-like (UBL) domains. Across coronaviruses, PLpro showed divergent selectivity for recognition and cleavage of posttranslational conjugates despite sequence conservation. We show that SARS-CoV-2 PLpro binds human ISG15 and K48-linked di-ubiquitin (K48-Ub(2)) with nanomolar affinity and detect alternate weaker-binding modes. Crystal structures of untethered PLpro complexes with ISG15 and K48-Ub(2) combined with solution NMR and cross-linking mass spectrometry revealed how the two domains of ISG15 or K48-Ub(2) are differently utilized in interactions with PLpro. Analysis of protein interface energetics predicted differential binding stabilities of the two UBL/Ub domains that were validated experimentally. We emphasize how substrate recognition can be tuned to cleave specifically ISG15 or K48-Ub(2) modifications while retaining capacity to cleave mono-Ub conjugates. These results highlight alternative druggable surfaces that would inhibit PLpro function.